Deal Us In
What You Need To Know
The current overdose crisis has moved beyond opioids alone. In 2019, nearly half of drug overdose deaths involved multiple drugs. - CDC Programs must reflect this new reality.
Where to Go for More Information
Policy Proposals to Reduce Drug-Related Harm: How To Address the 4th Wave of the Overdose Crisis - Drug Policy Alliance
Harm Reduction for Stimulant Use - Harm Reduction International, 2019
Stimulant Use: Harm Reduction, Treatment, and Future Directions - Drug Policy Alliance
Stimulant Overamping Basics - National Harm Reduction Coalition
What Is Overamping? - National Harm Reduction Coalition
Factsheet - Cocaine - Drug Policy Alliance
Factsheet - Meth - Drug Policy Alliance
Safer Drug Use 101 - National Harm Reduction Coalition
Bevel Up Safer Use Resource Collection - BevelUp and NASTAD
Research
Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence
Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials - Amin-Esmaeili et al, 2023
Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry - Fredericksen et al, 2024
Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada - Palis and MacDonald, 2023
Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention‑Deficit/Hyperactivity Disorder - Jeun and Al‑Mamun, 2024